Minimal residual disease: How low do we go?

被引：8

作者：

Bagg, A ^{[1
]}

机构：

[1] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

来源：

MOLECULAR DIAGNOSIS | 2001年 / 6卷 / 03期

关键词：

D O I：

10.2165/00066982-200106030-00002

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：155 / 160

页数：6

共 36 条

[1]

Bagg A, 1999, AM J CLIN PATHOL, V112, pS76

[2]

Biernaux C, 1996, BONE MARROW TRANSPL, V17, pS45

[3] Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].

Burnett, AK ;

Grimwade, D ;

Solomon, E ;

Wheatley, K ;

Goldstone, AH .

BLOOD, 1999, 93 (12) :4131-4143

[4]

Campana D, 1999, CYTOMETRY, V38, P139, DOI 10.1002/(SICI)1097-0320(19990815)38:4<139::AID-CYTO1>3.0.CO

[5]

2-H

[6] Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia [J].

Cavé, H ;

ten Bosch, JV ;

Suciu, S ;

Guidal, C ;

Waterkeyn, C ;

Otten, J ;

Bakkus, M ;

Thielemans, K ;

Grandchamp, B ;

Vilmer, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :591-598

[7]

Cimino G, 2000, BLOOD, V95, P96

[8] Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia [J].

Ciudad, J ;

San Miguel, JF ;

López-Berges, MC ;

Vidriales, B ;

Valverde, B ;

Ocqueteau, M ;

Mateos, G ;

Caballero, MD ;

Hernández, J ;

Moro, MJ ;

Mateos, MV ;

Orfao, A .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3774-3781

[9] Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia [J].

Coustan-Smith, E ;

Behm, FG ;

Sanchez, J ;

Boyett, JM ;

Hancock, ML ;

Raimondi, SC ;

Rubnitz, JE ;

Rivera, GK ;

Sandlund, JT ;

Pui, CH ;

Campana, D .

LANCET, 1998, 351 (9102) :550-554

[10]

Diverio D, 1998, BLOOD, V92, P784

← 1 2 3 4 →